Eltrombopag

Promacta

Brand for: Eltrombopag

CVS logo
CVS
$12,772.89
Walgreens logo
Walgreens
Pay Online$259.20
Albertsons logo
Albertsons
Pay Online$792.47
Walmart logo
Walmart
$12,245.29
Show this card to your pharmacist

Promacta Savings card

$259.20

BIN
019876
ID
LH097EC7BC
PCN
CHIPPO
GRP
LHX

Print or send this coupon to your phone

About Promacta

Drug Details

Eltrombopag, marketed as Promacta, is a medication primarily used to treat low platelet counts in individuals with certain blood disorders, such as chronic immune thrombocytopenic purpura (ITP) and severe aplastic anemia, as well as those with long-term hepatitis C. Platelets are crucial for blood clotting and preventing excessive bleeding. Eltrombopag works by mimicking thrombopoietin, a natural hormone that stimulates the bone marrow to produce more platelets, thereby reducing the risk of bleeding. This medication can be used alone or in combination with other treatments, depending on the condition being treated. Common side effects include nausea, fever, tiredness, and headache. It is important to consult a healthcare professional before starting this medication, as they can provide personalized advice and ensure it is safe and effective for your specific health needs.

Related Prescriptions

Promacta (Eltrombopag) dosage forms

DosageQuantityPrice fromPer unit
12.5MG30 Tablets$198.00$6.60
25MG30 Tablets$198.60$6.62
50MG30 Tablets$259.20$8.64
75MG30 Tablets$378.30$12.61

Promacta FAQs

Promacta is used to treat certain conditions that lead to low platelet counts, such as chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. It helps increase platelet production to reduce the risk of bleeding.

Promacta is not a chemotherapy drug. It is a medication used to treat low blood platelet counts in certain conditions, such as chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia. It works by stimulating the production of platelets in the bone marrow.

The cost of Promacta can be attributed to several factors. These include the research and development expenses involved in bringing the drug to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, Promacta is a specialized medication used to treat specific conditions, which can contribute to its higher price. Manufacturing costs, distribution, and the pricing strategies of pharmaceutical companies also play a role in the overall expense of the medication.

An alternative to Promacta (eltrombopag) could be Nplate (romiplostim), which is another thrombopoietin receptor agonist used to treat certain conditions like chronic immune thrombocytopenia (ITP). However, the choice of medication should be determined by a healthcare provider based on the patient's specific condition and medical history.

Medicare may cover Promacta under certain conditions. If Promacta is prescribed for an FDA-approved indication, it might be covered under Medicare Part D, which is the prescription drug plan. However, coverage can vary based on the specific plan, and prior authorization or step therapy might be required. It is advisable for individuals to check with their specific Medicare Part D plan provider to confirm coverage details and any associated costs.

Read All FAQs